USPTO serial 90238043
AUDUBON
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 4, 2022
- Examiner
- CHADAB, SETH WILLIG
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with AUDUBON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert Devin Ricci
Robert Devin Ricci KEAN MILLER LLP909 POYDRAS STREET, SUITE 3600NEW ORLEANS, LA 70112UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Providing medical and scientific research information in the field of human pharmaceuticals and human clinical trials; conducting research and clinical trials in the field of human oncology and cancer research; Providing a website featuring educational information in the field of human clinical research; Medical and scientific research, namely, conducting human clinical trials for others; Providing human medical testing services and information in the field of human cancer research and disease classification; technical research and consulting in the field of human pharmaceutical studies; Human pharmaceutical research services; human Pharmaceutical research and development; testing of human pharmaceuticals; Biotechnology research related to humans; Medical research related to humans; Human DNA analysis services for scientific research purposes; Human medical and scientific research in the field of molecular profiling and biomarker discovery in cancer patients; human medical and scientific research in the field of cancer treatment; Providing research information in the nature of human medical research data pertaining to cancer and its treatment; Management of clinical and translational trials in the field of human cancer treatment for others in the nature of conducting clinical trials for others; Providing clinical trial information in the nature of research data pertaining to cancer; development, validation, and certification of human clinical trials and tests; Design, research, development and testing services in the field of human pharmaceuticals, biobanking, and cancer research; Preclinical research services in the field of human biospecimens collections | ACTIVE | May 25, 2017 |
| 044 | collection and preservation of human biologicals, namely, human tissue, blood and bodily fluids; Biobank services, namely, providing access to a collection of human biologicals, namely, human tissue, blood and bodily fluids; Providing human medical information in the nature of medical data pertaining to cancer and its treatment; providing tissue biobank services, namely, access to a biobank of human biological and tissue samples; Human medical testing for diagnostic or treatment purposes; Dispensing of pharmaceuticals to humans | ACTIVE | May 25, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Audubon Health Group, LLC
- Other trademarks owned by Audubon Health Group, LLC
- Other trademarks owned by Audubon Health Group, LLC
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AUDUBON
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 4, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 25, 2021 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Nov 24, 2021 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Nov 24, 2021 | APET | ASSIGNED TO PETITION STAFF | — |
| Nov 12, 2021 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jun 16, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 18, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 18, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 28, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 13, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 13, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 13, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 13, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 13, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 9, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 21, 2020 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 20, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 9, 2020 | NWAP | NEW APPLICATION ENTERED | — |